Caxton Associates (New York)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-8,871
| Closed | -$590K | – | 533 |
|
|
2020
Q2 | $590K | Hold |
8,871
| – | – | 0.05% | 94 |
|
|
2020
Q1 | $543K | Sell |
8,871
-3,681
| -29% | -$225K | 0.1% | 141 |
|
|
2019
Q4 | $1.1M | Buy |
12,552
+3,687
| +42% | +$324K | 0.15% | 71 |
|
|
2019
Q3 | $669K | Buy |
8,865
+6,169
| +229% | +$466K | 0.13% | 83 |
|
|
2019
Q2 | $230K | Hold |
2,696
| – | – | 0.03% | 329 |
|
|
2019
Q1 | $291K | Buy |
+2,696
| New | +$291K | 0.04% | 251 |
|